Leapfrog diagnostics: Demonstration of a broad spectrum pathogen identification platform in a resource-limited setting

Tomasz A. Łęski, Rashid Ansumana, Anthony P. Malanoski, David Henry Jimmy, Umaru Bangura, Brian R. Barrows, Morie Alpha, Bashiru M. Koroma, Nina C. Long, Abu James Sundufu, Alfred S. Bockarie, Baochuan Lin, David A. StengerHealth Research Policy and Systems 2012 · DOI

Abstract

This paper, published in Health Research Policy and Systems, details a successful pilot program to establish a high-tech molecular diagnostic laboratory in Bo, Sierra Leone. By "leapfrogging" traditional infrastructure requirements through the use of solar power, satellite communication, and dry-reagent stabilization, the authors demonstrate that sophisticated pathogen surveillance is possible even in severely resource-limited environments.

Introduction

Tropical, resource-limited countries are often "hotspots" for emerging infectious diseases like Ebola or Lassa fever, yet they frequently lack the laboratory capacity to detect outbreaks early. The barriers are systemic: unreliable electricity makes sensitive equipment and freezers (the "cold chain") impossible to maintain, biological samples degrade during transport, and there is a shortage of highly trained personnel. The authors argue that instead of trying to replicate Western-style laboratories, these regions should "leapfrog"—skipping intermediate technological stages to adopt the newest systems designed to function without heavy infrastructure.

The "Leapfrog" Methodology

The team established a laboratory at Mercy Hospital in Bo, Sierra Leone, utilizing several key technologies:

  • Hybrid Power: A self-contained system combining solar panels, diesel generators, and battery storage provided stable power for sensitive instruments like the Affymetrix GeneChip scanner.
  • Satellite Communication: A stand-alone C-band satellite link enabled internet access for remote technical support and data exchange via Skype.
  • Sample Stabilization: They used FTA paper (filter paper impregnated with chemicals) to collect and store RNA/DNA at room temperature, eliminating the need for dry ice or freezers.
  • Resequencing Microarrays (RPM): Unlike standard PCR, which looks for one specific pathogen, RPM-Flu and RPM-TEI microarrays can simultaneously detect hundreds of different viral and bacterial pathogens.

Field Application and Data Collection

The study focused on a real-world application involving poultry samples collected from nine different farms across Sierra Leone. One farm was experiencing a significant 15% mortality rate among its chickens, providing a critical test case for the diagnostic platform.

Table 1: Details of farm locations and poultry samples collected in Sierra Leone.

Stability and Performance Benchmarking

A critical component of the "leapfrog" approach was the use of FTA paper to preserve samples without refrigeration. To benchmark this, the team tested Influenza B RNA at various concentrations under tropical heat conditions (up to 45°C).

Table 3: Stability of Influenza B RNA on FTA paper across various temperatures and durations.

As shown in the performance data, the FTA paper successfully preserved high viral loads ($10^6$ copies/µl) for at least 10 days at 45°C. However, the study also highlighted a limitation: detection became inconsistent at very low concentrations ($10^2$ copies/µl), indicating that while the technology is robust for outbreaks with high viral shedding, it may require further optimization for early-stage or low-load detection.

Key Results and Public Health Insights

  • Outbreak Investigation: The microarrays and follow-up RT-PCR excluded influenza viruses as the cause of the poultry deaths. Instead, the system identified Klebsiella pneumoniae in 73% of the samples from the affected farm, suggesting it was the likely culprit.
  • Zoonotic Risk: The lab detected the mecA gene (which confers methicillin resistance) in 10% of the samples. This indicates a reservoir of antibiotic-resistant bacteria in local livestock that could potentially jump to humans.
  • Operational Success: The lab remained functional through the dry season when the local power grid was almost entirely offline, proving that high-end genomics can be decoupled from the power grid.

Limitations and Future Outlook

While the pilot was successful, challenges remain. The cost per microarray ($100–$200) is still high for routine use in developing nations, and the turnaround time in this pilot was delayed by logistical hurdles. The authors conclude that for real-world utility, the supply chain for reagents must be streamlined and stabilized kits must be further optimized to allow for sustainable, real-time remote diagnostics.

Summary updated

BibTeX
@inproceedings{eski2012leapfrog,
  author = {Tomasz A. Łęski and Rashid Ansumana and Anthony P. Malanoski and David Henry Jimmy and Umaru Bangura and Brian R. Barrows and Morie Alpha and Bashiru M. Koroma and Nina C. Long and Abu James Sundufu and Alfred S. Bockarie and Baochuan Lin and David A. Stenger},
  title = {{Leapfrog diagnostics: Demonstration of a broad spectrum pathogen identification platform in a resource-limited setting}},
  booktitle = {Health Research Policy and Systems},
  year = {2012},
  doi = {10.1186/1478-4505-10-22},
}
Figure